HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹1,590 Cr | ₹1,621 Cr | ₹1,446 Cr | ₹1,305 Cr | ₹1,091 Cr |
What is the latest Total Non-Current Assets ratio of HIKAL ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹1,590 Cr |
| Mar2024 | ₹1,621 Cr |
| Mar2023 | ₹1,446 Cr |
| Mar2022 | ₹1,305 Cr |
| Mar2021 | ₹1,091 Cr |
How is Total Non-Current Assets of HIKAL Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,590 Cr | -1.93 | |
| Mar2024 | ₹1,621 Cr | 12.05 | |
| Mar2023 | ₹1,446 Cr | 10.86 | |
| Mar2022 | ₹1,305 Cr | 19.64 | |
| Mar2021 | ₹1,091 Cr | - | |
Compare Total Non-Current Assets of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,678.1 Cr | -4.6% | -0.4% | -40% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -4.6% |
-0.4% |
-40% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses